Adults meeting DSM-IV-TR criteria for bipolar I disorder and currently experiencing a major depressive episode while taking at least @ weeks of conventional maintenance medication were enrolled in a placebo-controlled evaluation of adjunctive armodafinil @ or @ mg ( conducted January @-March @ ) .